TGFB1 and breast cancer: Given the central role of Smad4 in the signaling of all TGF-β-related superfamily members, reduced or absent Smad4-expression as described here would be expected to alter the signaling not only of TGF-β, but also of the BMPs and activins, which also can inhibit proliferation of breast cancer cells [39-41].